Search by Drug Name or NDC

    NDC 00078-0562-15 Exforge HCT 10; 25; 160 mg/1; mg/1; mg/1 Details

    Exforge HCT 10; 25; 160 mg/1; mg/1; mg/1

    Exforge HCT is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN.

    Product Information

    NDC 00078-0562
    Product ID 0078-0562_27060f73-ac96-4d1a-96c1-1e9825a7590c
    Associated GPIs 36994503200335
    GCN Sequence Number 065151
    GCN Sequence Number Description amlodipine/valsartan/hcthiazid TABLET 10-160-25 ORAL
    HIC3 A4V
    HIC3 Description ANGIOTEN.RECEPTR ANTAG-CALCIUM CHANL BLKR-THIAZIDE
    GCN 22649
    HICL Sequence Number 036305
    HICL Sequence Number Description AMLODIPINE BESYLATE/VALSARTAN/HYDROCHLOROTHIAZIDE
    Brand/Generic Brand
    Proprietary Name Exforge HCT
    Proprietary Name Suffix n/a
    Non-Proprietary Name amlodipine valsartan and hydrochlorothiazide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 10; 25; 160
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN
    Labeler Name Novartis Pharmaceuticals Corporation
    Pharmaceutical Class Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], In
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA022314
    Listing Certified Through 2024-12-31

    Package

    NDC 00078-0562-15 (00078056215)

    NDC Package Code 0078-0562-15
    Billing NDC 00078056215
    Package 30 TABLET, FILM COATED in 1 BOTTLE (0078-0562-15)
    Marketing Start Date 2009-04-04
    NDC Exclude Flag N
    Pricing Information N/A